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Chinese Hamster Ovary (CHO) cells are widely used in
biomanufacturing and biomedical research to produce
proteins of clinical significance. The environment the
cells grow in to produce these proteins is complex and
varies across the industry. One key variable in produc-
tion processes is the cell culture medium used. Media
can include chemically-defined components such as
amino acids, vitamins, lipids, metal salts, and buffers. In
addition, undefined components such as proteins,
serum, or hydrolysates may be added. To reduce com-
plexity, increase consistency, and comply with increasing
demands from regulatory entities, chemically-defined
formulations are preferred and can be developed and
optimized for a given cell line. While a medium and
feed can be optimized for every cell line/clone, develop-
ing a platform system provides a cost-effective option
while ensuring a high level of growth and productivity.
In this collaboration, between Life Technologies PD-
Direct® and CMC Biologics, a single animal origin-free,
hydrolysate-free base platform medium and three syner-
gistic feed media were developed for use with recombinant
CHO cell lines engineered using the CHEF1® expression
system to produce monoclonal antibodies. The CHEF1
expression system utilizes regulatory domains from the
Chinese hamster elongation factor 1 (EF1a) gene to drive
production of heterologous proteins [1]. Serum-free, sus-
pension adapted CHO DG44 cells were transfected with
CHEF1 plasmids harboring 2 different IgG1 MAb genes
and used as test cell lines to develop a platform feed sys-
tem. A cell culture production platform system (CHEF1,
base medium, feed media) was developed and optimized
using two cell lines that were previously grown in an
undefined culture system. The new platform growth sys-
tem developed here, showed an average 1.6 fold improve-
ment in titer for the two cell lines compared to the
performance using the undefined culture system.
Using Design of Experiment (DOE) methods, we per-
formed a Feed Mixtures experiment and a 2-Level Cate-
goric experiment in shake flasks (culture parameters are
shown in Table 1). Cell counts and viabilities were deter-
mined using a Cedex AS20 automated cell counter (Inno-
vatis Inc.). Product titer was measured by Protein A
HPLC. Performance data from the Feed Mixtures experi-
ment were analyzed using Design Expert® (Stat-Ease®).
Select spent media samples from the best performing
Feed Mixtures conditions were analyzed for glucose,
amino acids and select water-soluble vitamins using
immobilized enzyme (YSI Life Sciences), UPLC (Waters
AccQ-Tag™ - reverse phase with UV detection) and
HPLC (ion-pair reverse phase using a UV detection),
respectively. The Feed mixtures data were used to calcu-
late nutrient consumption rates, which in turn were used
to develop 3 balanced feeds (at neutral pH). A separate
Feed Supplement (at high pH) was designed to facilitate
delivery of components that were needed at levels above
solubility limits in a neutral solution. These feeds and the
Feed Supplement were then tested in a 2-Level Categoric
experiment, evaluating feed volume, feed schedule, and
the feed supplement. Performance data from this experi-
ment were analyzed using Design Expert. Select spent
media samples from the best performing conditions were
analyzed for glucose, amino acids and select water-solu-
ble vitamins. These data demonstrated that the three
feeds were balanced and, when the feed supplement was
included, provided nutrients at levels sufficient for con-
tinued growth/productivity. The best performing feed
system (balanced feed [BF1] and feed supplement [FS])
was used in a bioreactor confirmatory experiment
* Correspondence: william.paul@lifetech.com
1Life Technologies Corporation (PD-Direct® Bioprocess Services), 3175 Staley
Road, Grand Island, NY, 14072 USA
Full list of author information is available at the end of the article
Paul et al. BMC Proceedings 2013, 7(Suppl 6):P98
http://www.biomedcentral.com/1753-6561/7/S6/P98
© 2013 Paul et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
(culture parameters shown in Table 1). In addition, a day
0 feed was designed (BF5 - included recombinant growth
factors) and tested in the bioreactor.
Supplementing BF5 at 3% (v/v) prior to inoculation
and feeding 4%BF1 on day 4, 5% on day 6, 3% on day 8,
2% on day 10, and 1% (v/v) on days 12 and 14 and FS
at 0.2% (v/v) on alternate days starting on day 3 pro-
vided an environment for both cell lines that resulted in
productivity superior to the control condition; cell line
#1 reached 1.1 gm/L (control = 0.5 gm/L) and cell line
#2 reached 2.0 gm/L (control = 1.6 gm/L).
Since the cost of dry format media is more econom-
ical than liquid media at GMP scale, the feeds were con-
verted from liquid format to dry formats; BF1 was
converted to Advanced Granulated Technology™
(AGT™) format and the Feed Supplement was con-
verted to a dry powder media (DPM). Once hydrated,
these feeds were tested to confirm equivalency, achiev-
ing similar growth and productivity patterns as their
liquid counterparts. Additionally, these feeds have been
concentrated to reduce the dilution effect that many
commercial feeds produce, resulting in an approximate
76% reduction in feed volume added over the life of the
culture (Figure 1). This is a significant reduction in the
volume of fluid requiring in-process handling and down-
stream processing; saving time, equipment, and money.
This feed system development collaboration yielded a
112% improvement (over the control condition) in pro-
duct titer for cell line #1 and a 25% improvement in pro-
duct titer for cell line #2 (Figure 1). The base medium
and the newly developed final feed system provide an
animal origin-free, hydrolysate-free growth environment.
For the purposes of many commercial cGMP processes,
this culture system provides an economical solution.
Addition of a proprietary undefined feed (CMC Biolo-
gics), prior to inoculation, on top of this balanced feed
system has been shown to boost productivity by about
15% over using just the balanced feed system. Next steps
include evaluating protein quality and validating at pro-
duction scale.
Table 1 Culture Parameter Conditions and Set-Points
Parameters
Shake Flask/Culture Volume 125 mL vented Erlenmeyer 30 mL working volume
Bioreactor/Culture Volume 3 L single-use CellReady bioreactor 2 L working volume
Seeding Density 5x105 viable cells/ mL
Temperature 37°C ± 0.5°C (days 0 - 4) 34°C ± 0.5°C (day 5 - end)
CO2 Level (Shake Flask) 6% ± 1% (days 0 - 4) 2% ± 1% (day 5 - end)
pH (Bioreactor) 7.0 ± 0.2
RPM (Shake Flask) 120 ± 5
RPM (Bioreactor) 200 ± 10
Dissolved Oxygen (Bioreactor) 60% ± 5%
Figure 1 Summary of Optimization Collaboration - Improved titer by 112% (cell line #1), by 25% (cell line #2), and reduced volume
fed by 76%.
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